Skip to main content
Intercure Ltd. logo

Intercure Ltd. — Investor Relations & Filings

Ticker · INCR ISIN · IL0011063760 LEI · 549300KI5ESXF8F5GP06 TA Manufacturing
Open in API
Filings indexed 334 across all filing types
Latest filing 2023-04-20 Foreign Filer Report
Country IL Israel
Listing TA INCR

About Intercure Ltd.

https://www.intercure.co

Intercure Ltd. is a company focused on the production and distribution of pharmaceutical-grade medical cannabis and cannabis-based products. Operating primarily through its wholly-owned subsidiary, Canndoc Ltd., the company is a licensed producer of Good Manufacturing Practice (GMP) certified medical cannabis. Intercure's strategy involves international expansion through strategic partnerships, such as producing and distributing established brands like Cookies in European markets, and through acquisitions to access premium technologies and brands. The company leverages its EU-GMP certified manufacturing facilities to supply its products for medical use across its operational territories.

Recent filings

Filing Released Lang Actions
Foreign Filer Report 2023
Foreign Filer Report
2023-04-20 English
InterCure Announces Reschedules 2022 Full Year Results Conference Call
Report Publication Announcement Classification · 1% confidence The document explicitly states that InterCure has 'rescheduled its previously announced conference call to discuss the company's financial results for the full year ended December 31, 2022.' This is an announcement about an upcoming event where results will be discussed, not the results themselves (ER) or the transcript of the call (CT). Since the document is an announcement regarding the timing/scheduling of a report/discussion event, it fits the definition of a Report Publication Announcement (RPA). The document length is short (1986 chars), supporting the 'announcement' classification over the full report.
2023-04-04 English
InterCure Announces Reschedules 2022 Full Year Results Conference Call
Report Publication Announcement Classification · 1% confidence The document is very short (1803 characters) and explicitly states, "Attached hereto is a report on *PR_reschedualing_isa.pdf*". This structure—a brief filing announcing the attachment or publication of a separate, detailed report—fits the definition of a Report Publication Announcement (RPA). It is not the full report itself (like 10-K or IR). The filing is made to the Israel Securities Authority (ISA) and the Tel Aviv Stock Exchange (TASE) under immediate report regulations.
2023-04-04 English
Foreign Filer Report 2023
Foreign Filer Report
2023-04-03 English
Foreign Filer Report 2023
Foreign Filer Report
2023-04-03 English
Fourth Quarter and Fiscal Year End 2022 Results
Earnings Release Classification · 1% confidence The document is a press release announcing the financial and operating results for the fourth quarter and fiscal year ended December 31, 2022. It contains key highlights, comparative tables of financial metrics (Revenues, Adjusted EBITDA), and explicitly mentions that the full audited financial statements and accompanying notes, along with the Management's Discussion and Analysis (MD&A), are available on SEDAR. The document itself is a summary/release of results, not the comprehensive annual report (10-K) or the full MD&A. Key indicators pointing away from 10-K or IR: 1. The title is an 'Announcement' of results. 2. It references the full financial statements and MD&A being available elsewhere ("InterCure's audited financial statements and accompanying notes... together with its Annual Information Form... are available under the Company's profile on SEDAR."). 3. The document concludes with the start of the MD&A section, suggesting this press release serves as the initial announcement. This structure strongly aligns with an Earnings Release (ER), which provides the key highlights before the full regulatory filings are distributed or consumed. It is not a 10-K because it is a press release summarizing the year-end results and directing users to the full filings (including the MD&A, which is partially included but framed as supplementary to the audited statements). It is not an IR (Interim Report) because it covers the full fiscal year end, which typically defaults to 10-K territory, but since this is the *release* announcing the results, ER is the most appropriate classification for the press release format. FY 2022
2023-04-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.